ethosuximide has been researched along with Hearing Loss in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ethosuximide was administered by intraperitoneal injection every other day from post-natal day seven (P7) until the mice were 8 weeks of age." | 5.46 | Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss. ( Entenman, S; Ma, X; Min, L; Sang, L; Su, Y; Zhang, X; Zheng, Q; Zheng, T, 2017) |
| "Ethosuximide was administered by intraperitoneal injection every other day from post-natal day seven (P7) until the mice were 8 weeks of age." | 1.46 | Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss. ( Entenman, S; Ma, X; Min, L; Sang, L; Su, Y; Zhang, X; Zheng, Q; Zheng, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sang, L | 1 |
| Zheng, T | 1 |
| Min, L | 1 |
| Zhang, X | 1 |
| Ma, X | 1 |
| Entenman, S | 1 |
| Su, Y | 1 |
| Zheng, Q | 1 |
1 other study available for ethosuximide and Hearing Loss
| Article | Year |
|---|---|
Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss.
Topics: Aging; Animals; Apoptosis; Calcium Channels, T-Type; Calcium Signaling; Cochlea; Ethosuximide; Heari | 2017 |